Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure
NCT ID: NCT02118389
Last Updated: 2014-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2013-10-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism
NCT04283942
Training in the Fasted State, Glucose Metabolism and Energy Balance
NCT02744183
The Impact of Low Glycemic Index Nutritional Shake on Glucose Regulation in Overweight and Obese Adults
NCT06856460
Meta-analyses of the Effect of Liquid Meal Replacements on Cardiometabolic Risk
NCT02779790
The Influence of Glucose Flux on Fat Synthesis in a Whole Body Calorimeter
NCT02631083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glucerna,Meal Replacement
Glucerna 52g instead of night meal 5weeks
Glucerna
Glucerna 52g meal replacement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glucerna
Glucerna 52g meal replacement
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. BMI ≥ 28kg/m2
3. without liver, kidney, gastrointestinal and other major organic serious diseases,lactating women, pregnancy
14 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai 10th People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhang Manna
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qu Shen, PhD
Role: STUDY_DIRECTOR
Shang Tenth People's Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Glucerna
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.